Johnson & Johnson CEO Joaquin Duato’s total compensation was about $24.3 million in 2024, according to a Securities and Exchange Commission proxy filing.
The company’s March 12 filing revealed the compensation packages for five executives from 2022 to 2024. Compensation packages include salary, stock and option awards, non-equity incentive plan compensation and other forms of pay.
Joaquin Duato, chair and CEO
2024: $24.3 million
2023: $28.4 million
2022: $13.1 million
Joseph Wolk, executive vice president and CFO
2024: $12.6 million
2023: $14 million
2022: $8.8 million
Tim Schmid, executive vice president, worldwide chair of innovative medicine
2024: $11.9 million
Jennifer Taubert, executive vice president and worldwide chair of pharmaceuticals
2024: $11.2 million
2023: $11 million
2022: $8.8 million
John Reed, MD, PhD, executive vice president of innovative medicine and research and development
2024: $9.3 million
2023: $20.6 million
